MIRACLE-EAR

Item 7 details the initial investment from $120,000 to $402,500, including a flat $30,000 franchise fee (Item 5) covering training and territory rights. Ongoing fees ditch traditional royalties for fixed charges per hearing aid—$48.80 for Miracle-Ear models and $30.15 for AudioTone Pro—plus a brand fund levy of $25-$75 per unit and monthly software costs starting at $101 for Sycle.net up to $570 for CRM. Item 19 shines here: average gross revenue hits $452,474 across comparable outlets, but the median lags at $392,569, suggesting top performers skew the mean while half fall below $400K. SBA data reinforces scale, with just 12 loans averaging $457,267, indicating franchisees often fund larger builds without heavy federal backing.

System health raises flags in Item 20: locations contracted 6% from 1,274 in 2023 to 1,192 in 2024, despite demographic tailwinds and regulatory easing for over-the-counter aids. This shrinkage—amid low termination rates but possibly higher non-renewals—hints at maturation challenges for a franchisor under Amplifon (USA), Inc. For investors eyeing healthcare services, the model's regulatory compliance and exclusive territories promise stability, but modest revenues demand high-volume sales to offset $300K+ buildouts. Crunching these metrics, Miracle-Ear suits experienced operators targeting boomers, yet the dip urges scrutiny of local competition and multi-unit scalability before committing.